Theme: Frontiers in Transplantation Science for Promising Future
TRANSPLANTATION SCIENCE 2019
Conference Series LLC LTD invites all the participants from all over the world to attend ‘International Conference on Organ Donation and Transplantation Science' during July 15-16, 2019 Sydney, Australia which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Transplantation Science 2019 is the premier event that brings together a unique and international mix of experts, researchers and decision makers both from academia, medical and hospitals across the globe to exchange their knowledge, expertise and research innovations to build world class expert Doctors.
It’s our greatest pleasure to welcome you to the official website of ‘International Conference on Organ Donation and Transplantation Science’ that aims at bringing together the Professors, Researchers, Doctors, and Surgeons to provide an international forum for the dissemination of original research results, new ideas and practical development experiences which concentrate on both theory and practices. The conference will be held in July 15-16, 2019 Sydney ,Australia. The theme of the conference is “Frontiers in Transplantation Science for Promising Future”. Featuring 2-days of scientific workshop, special sessions, speaker & poster session, Industrial Expo. 300+ attendees from all over the world.
The event focuses on aspects such as Organ Transplantation Surgery, Heart Transplant Surgery, Liver Transplantation, Kidney Transplantation, Lungs Transplantation, Gender reassignment Surgery and Transplantation Techniques as well understanding tools to overcome barrier and enable successful data analysis and management. Conference Series LLC Ltd organizes of 1000+ Global Events inclusive of 300+ Conferences, 500+ Upcoming and Previous Symposiums and Workshops in USA, Europe & Asia with support from 1000 more scientific societies and publishes 700+ Open access journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.
Why to attend???
With members from around the world focused on learning about Organ Transplantation and its advances; this is your best opportunity to reach the largest assemblage of participants from the Organ Donation and Transplantation Science community. Conduct presentations, distribute information, meet with current and potential scientists, make a splash with new advancements and developments, and receive name recognition at this 2-days event. World-renowned speakers, the most recent techniques, developments, and the newest updates in Organ Transplantation are hallmarks of this conference.
- Heart surgeons
- Scientists
- Researchers
- Expert Surgeons
- Doctors
- Dermatologists
- Organ Transplantation Associations
- Organ Transplantation Societies
- Business Entrepreneurs
- Training Institutes
- Hospitals
- Manufacturing Medical Devices Companies
For more information: https://world.geneticconferences.com/
Sessions/Tracks
Track 1 Organ Transplantation Surgery:
Organ Transplantation Surgery is a beneficial technique in which a section of tissue or a complete organ that is removed from its original natural site and transferred to a new position in the same person or in a separate individual. The donated organ may be from a deceased donor, a living donor. In some cases an artificial organ are also used.
WHO Global Observatory on Donation and Transplantation (GODT), Ethical, Legal and Psychosocial Aspects of Organ Transplantation (ELPAT), Donation and Transplantation Institute (DTI), International Society for Heart and Lung Transplantation (ISHLT)
Track 2 Organ Donations:
Organ donation is an act of giving one or more organs without compensation for transplantation into someone else. Organ donation is a very personal yet complex decision, intertwined with medical, legal, religious, cultural, and ethical issues. Donations include the liver, kidney, pancreas, and heart.
International Society for Organ Donation and Procurement (ISODP), International Transplant Nurses Society (ITNS), Transplantation Society of Australia and New Zealand, Australia: Organ and Tissue Authority, Philippines: National Kidney and Transplant institute, Japan: Japan Organ Transplant Network, Malaysia: Malaysia Society of Transplantation
Track 3 Liver Transplantation:
Liver transplant is a surgical procedure to remove a diseased liver and replace it with a healthy liver from a donor. Most liver transplant operations use livers from deceased donors, though a liver may also come from a living donor. The liver has sizable reserves and a great capacity to regenerate itself. Often, symptoms aren't evident until significant damage has been done. At present, there is no known way to medically compensate for the loss of a liver.
Saudi Centre for Organ Transplantation, Middle East Society for Organ Transplantation (MESOT), Israel: ADI - National Transplant Center, European Society of Transplantation, Belgian Transplantation Society, Denmark: Dansk Transplantations selskab, France: French Federation for Organ Donation, Germany: Deutsche Stiftung Organ transplantation (DSO), Greece: Hellenic National Transplant Organization
Track 4 Kidney Transplantation:
Kidney transplant is a treatment for persons who have chronic renal failure requiring dialysis. Kidney transplants are among the most commonly performed types of transplant surgery. Kidneys often are donated from living relatives to ensure the greatest prospects of long-term survival and today, more than four-fifths of patients with transplanted kidneys will survive for more than five years.
Hellenic National Transplant Organization, Italy: Centro National Trapianti (CNT), Poland: Poltransplant, Spain: Organization National de Transplants (ONT)
Track 5 Heart Transplantation:
Heart transplantation is the replacement of a patient's diseased or injured heart with a healthy donor heart. Heart Transplantation is a treatment option for people who are in the end stages of heart failure. Heart transplant surgery lasts for approximately four hours. During that time, you’ll be placed on a heart-lung machine to keep blood circulating throughout your body.
European Society of Transplantation, Belgian Transplantation Society, Denmark: Dansk Transplantations selskab, France: French Federation for Organ Donation, Germany: Deutsche Stiftung Organ transplantation (DSO), Greece: Hellenic National Transplant Organization
Track 6 Robotics Transplantation:
Robotic Transplantation is a robot-assisted surgery that aids surgeons in executing the most complex operations with extreme accuracy, mobility, and control as compared to the traditional procedures. The most widely used clinical robotic surgical system includes a camera arm and mechanical arms with surgical instruments attached to them. The surgeon controls the arms while seated at a computer console near the operating table. The console gives the surgeon a high-definition, magnified, 3-D view of the surgical site.
Saudi Centre for Organ Transplantation, Middle East Society for Organ Transplantation (MESOT), Israel: ADI - National Transplant Center, European Society of Transplantation, Belgian Transplantation Society, Denmark: Dansk Transplantations selskab, France: French Federation for Organ Donation, Germany: Deutsche Stiftung Organ transplantation (DSO)
Track 7 Medical Device Industry:
The Medical device industry makes an enormous number of products ranging from surgical gloves to artificial joints to imaging equipment and plays a crucial role in developing new medical technologies that can improve the ability to diagnose and treat illness. The industry has a relatively small number of large, diversified companies and a large number of smaller companies that are mainly engaged in research and development of new devices for specific therapeutic areas. The industry is distinctive both for its tendencies to make frequent, incremental changes to its products and its extensive ties with physicians.
Organ and Tissue Authority, Philippines: National Kidney and Transplant institute, Japan: Japan Organ Transplant Network, Malaysia: Malaysia Society of Transplantation, Singapore: National Organ Transplant Unit, Saudi Arabia: Saudi Centre for Organ Transplantation, Middle East Society for Organ Transplantation (MESOT), Israel: ADI - National Transplant Center, European Society of Transplantation
Track 8 Gender Reassignment Surgery:
Gender reassignment surgery sometimes called Sex reassignment surgery, is implemented to transition individuals with gender dysphonia to their desired gender. Gender reassignment is irrelevant to a person’s ability to perform a job. Indeed, having previously had to live with the pressure of gender dysphonia, a transsexual person who has completed a change of gender identity is likely to emerge a better worker than before.
Global Observatory on Donation and Transplantation (GODT), Ethical, Legal and Psychosocial Aspects of Organ Transplantation (ELPAT), Donation and Transplantation Institute (DTI), International Society for Heart and Lung Transplantation (ISHLT)
Track 9 Transplantation Techniques:
In Transplantation technique a complete organ that is removed from its original natural site and transferred to a new position in the same person or in a separate individual. The term, like the synonym graft, was borrowed from horticulture. Both words imply that success will result in a healthy and flourishing graft or transplant, which will gain its nourishment from its new environment.
International Society for Organ Donation and Procurement (ISODP), International Transplant Nurses Society (ITNS), Transplantation Society of Australia and New Zealand, Australia: Organ and Tissue Authority, Philippines: National Kidney and Transplant institute, Japan: Japan Organ Transplant Network, Malaysia: Malaysia Society of Transplantation
Track 10 Bone Marrow transplantation:
A bone marrow transplant involves taking cells that are normally found in the bone marrow, filtering those cells, and giving them back either to the patient they were taken from or to another person. The goal of BMT is to transfuse healthy bone marrow cells into a person after his or her own unhealthy bone marrow has been eliminated.
Saudi Centre for Organ Transplantation, Middle East Society for Organ Transplantation (MESOT), Israel: ADI - National Transplant Center, European Society of Transplantation, Belgian Transplantation Society, Denmark: Dansk Transplantations selskab, France: French Federation for Organ Donation, Germany: Deutsche Stiftung Organ transplantation (DSO)
Track 11 Burn Repair Surgery:
This involves the removal of healthy skin tissues from one part of the body and transplanting it to the burn site. This skin graft may include only a few outer layers of skin or may involve the entire dermis. This is used in cases of severe burns where a large section of the dermis is affected. This procedure has many advantages as the skin colour and texture are a near perfect match thus reducing scarring to a large extent.
Organ and Tissue Authority, Philippines: National Kidney and Transplant institute, Japan: Japan Organ Transplant Network, Malaysia: Malaysia Society of Transplantation, Singapore: National Organ Transplant Unit, Saudi Arabia: Saudi Centre for Organ Transplantation, Middle East Society for Organ Transplantation (MESOT), Israel: ADI - National Transplant Center, European Society of Transplantation
Track 12 Bridges for Transplantation:
A generic term for any organ or surrogate device used to stabilize a patient before definitive transplantation of a matched organ.
Global Observatory on Donation and Transplantation (GODT), Ethical, Legal and Psychosocial Aspects of Organ Transplantation (ELPAT), Donation and Transplantation Institute (DTI), International Society for Heart and Lung Transplantation (ISHLT)
Track 13 Transplant Rejections:
Transplant Rejection happens when a person receives an organ from someone else during transplant surgery, that person's immune system may recognize that it is foreign. This is because the person's immune system detects that the antigens on the cells of the organ are different or not "matched." Mismatched organs, or organs that are not matched closely enough, can trigger a blood transfusion reaction or transplant rejection.
International Society for Organ Donation and Procurement (ISODP), International Transplant Nurses Society (ITNS), Transplantation Society of Australia and New Zealand, Australia: Organ and Tissue Authority, Philippines: National Kidney and Transplant institute, Japan: Japan Organ Transplant Network, Malaysia: Malaysia Society of Transplantation
Track 14 Organ Transport Systems:
In Organ transport system the organs are placed in sterile containers, packaged in wet ice, and transported to the recipient's transplant center. Hearts and lungs must be transplanted within approximately four hours after being removed from the donor in transport system.
Hellenic National Transplant Organization, Italy: Centro Nazionale Trapianti (CNT), Netherlands: Nederlandse Transplantatie Vereniging, Spain: Organization National de Transplants (ONT)
Track 15 Commercialization of Organs:
Commercialization of Organs in itself cannot be held as immoral. The premier and essential objection to the sale of human body parts on secular grounds is that commercialization would tend unavoidably to harm sellers. More specifically, the basic concern here is that due to the sup-posed inevitability of exploitation and coercion, the sale of human body parts cannot be contained in a just health care system. We will address this core secular argument in terms of its two separable, primary elements: exploitation and coercion.
Saudi Centre for Organ Transplantation, Middle East Society for Organ Transplantation (MESOT), Israel: ADI - National Transplant Center, European Society of Transplantation, Belgian Transplantation Society, Denmark: Dansk Transplantationsselskab, France: French Federation for Organ Donation, Germany: Deutsche Stiftung Organ transplantation (DSO)
Track 16 Legal and Ethical aspects:
The legislation called the Transplantation of Human Organ Act (THO) was passed in 1994 to streamline organ donation and transplantation activities. Broadly, the act accepted brain death as a form of death and made the sale of organs a punishable offence. With the acceptance of brain death, it became possible to not only undertake kidney transplantations but also start other solid organ transplants like liver, heart, lungs, and pancreas. Parallel to the living related and unrelated donation program, the deceased donation program has slowly evolved. In approximately one-third of all liver transplants, the organs have come from the deceased donor program as have all the hearts and pancreas transplants. In these states, a few hospitals along with committed NGOs have kept the momentum of the deceased donor program.
To overcome organ shortage, developed countries are re-looking at the ethics of unrelated programs and there seems to be a move towards making this an acceptable legal alternative. The ethics of commerce in organ donation and transplant tourism has been widely criticized by international bodies. The legal and ethical principles that we follow universally with organ donation and transplantation are also important for the future as these may be used to resolve our conflicts related to emerging sciences such as cloning, tissue engineering, and stem cells
The presence of a growing middle class, the lack of a national health insurance scheme, the growing disparity between the rich and poor, and to some extent the presence of technology makes the process of commodification of organs a simple, quick, and attractive business proposition for some and a solution for others. The more recent live liver donation program has also been influenced by kidney donation and unrelated living donations have been reported in the media including two deaths. Although kidney donation is a relatively safe surgery, the rising incidence of diabetes and hypertension in India makes the young donors potentially risk their health in the long-term. In some of the studies, it has been noted that when the motive of donation has been purely commercial, donors in the post-operative period have been more prone to ill-health. Whereas when the donation was purely altruistic, there was the feel-good factor and the psychological recovery was much better.
Track 17 Socioeconomic factors:
Socioeconomic factors have been shown to affect health care outcomes. Poverty, unemployment, and low education level have been listed among the factors that adversely affect health.
Transplantation noncompliance: occupational status, educational level, language or cultural barriers, and ethnic background. Race and income have substantial effects on mortality and use of services among Medicare beneficiaries. Poor individuals are less likely than wealthy individuals to be medically suitable, to be interested in transplantation, and to complete the pre- transplantation workup
Based on UNOS data, in patients with liver transplant, it has been shown that neighbourhood income had no effect on graft or patient survival, education had only marginal influence on the outcome (survival was lower in those with a high school education than in those with graduate education), and patients with Medicaid and Medicare had lower survival when compared with those with private insurance .The results of our study that was done in kidney transplant recipients are similar. In the entire patient group, there is a statistically significant benefit to graft and patient survival from having private insurance compared with Medicare. This effect was observed across almost all racial groups (except for Asian patients, for whom there was no significant association between private insurance and graft survival). HMO/PPO was associated with significantly higher risk for graft failure but improved patient survival. These results are similar to those reported in liver transplant recipients.
Donor rates in Australia
Australian donor rates are on the rise. Between 2009 and 2013, donor numbers increased by 29%. In 2009 there were 11.4 donors per million of the population. By 2013 there were 16.9 donors per million of the population. In Australia around 1600 people are on the organ transplant waiting list at any time. Less than 1% of persons whose death is in hospital can be potential donors because of the limited circumstances for which organ donation is possible. In 2013 only 40% of patients on the organ wait list received a transplant and 2% of the patients on the waiting list died while waiting for an organ.
Donor rates in Australia per million population.
Year |
Organ donors per million population |
Organ transplant recipients per million population |
Organs transplanted per million population |
2009 |
11.4 |
37.2 |
39.5 |
2010 |
14 |
42.8 |
45.1 |
2011 |
15.1 |
45.2 |
47.3 |
2012 |
15.6 |
46.3 |
48.8 |
2013 |
16.9 |
48.5 |
50.9 |
Table 1.3 source: Australian Government Organ and Tissue Donation and Transplantation Authority (2014). Annual Report.
Transplanted organs 2014 in Australia
Organ |
Number |
Kidneys |
659 |
Livers |
237 |
Hearts |
79 |
Heart/Lungs |
4 |
Lungs |
159 |
Pancreas (including pancreas islets) |
54 |
Total |
1,193 |
Australian Government Organ and Tissue and Transplantation Authority (2014). Facts and Statistics.
Australian Organ Donor Register
The Australian Organ Donor Register is a government register. People can register to be organ donors or they can register that they wish to not be an organ donor. The register is nationwide and is the only register in Australia. Registering is simple and can be done online at the Donate life.
Organ transplantation 2018 Report
World congress on Organ transplantation and artificial Organs was hosted by the Conference Series LLC LTD at Tokyo, Japan during August 24-25, 2017 with the theme “Explore and Exploit the Novel Techniques to Repair, Restore and Regenerate”.
The conference marked its start by an opening ceremony which included introduction by the Honourable Guests and the Members of Keynote Forum. All the speakers have extended their contribution in the form of highly informative presentations to lead the conference to the ladder of success.
Conference Series extends its warm gratitude towards all the Participants, Eminent Speakers, Young Researchers, Delegates and Students.
We would like to specially thank the following people who laid the foundation for the event’s success
Organizing Committee Members:
- Medhat Askar- Director, Transplant ommunology, Baylor university,USA
- Walter G.Land- professor, University of stasbourg, France
- Elmar jaeckel- Professor, Hannover Medical School, Germany
- Matteo Ravaioli- Doctor, University of bologna, Italy
- Janez Rozman- Doctor, University of Ljubljana, solvenia
- Edyta Skwirczynska- Associate Professor, Pomeranian medical university, poland
- Fariborz Tavangarian-Associate Professor, Pennsylvania state University, USA
Keynote Speakers:
- Bruce Geleb- NYU Langone Transplant Institute, USA
- Chris Elliott- Leman Micro Devices SA, Switzerland
- Sujata Malik- Sunburst Healthcare Pvt. Ltd., India
- Masahiro Onuma- TriSGuide Ltd, Japan
- Mditsheni J Ramakuela- University of Venda, South Africa
- Yoshiaki Omura- International College of Acupuncture & Electro-Therapeutics, USA
- Hiroshi Ohrui- Yokohama University of Pharmacy, Japan
After the huge optimistic response from scientific fraternity, renowned personalities and the Editorial Board Members of Conference Series LLC LTD Group from across the world we are pleased to announce the 8th International Conference on Organ donation and transplantation to be held during July 15-16, 2019 at Sydney, Australia.
Let us meet again @ Transplantation science 2019
Conference Highlights
- Organ Transplantation Surgery
- Liver Transplantation
- Kidney Transplantation
- Heart Transplantation
- Robotics Transplantation
- Medical Device Industry
- Gender Reassignment Surgery
- Transplantation Techniques
- Bone Marrow transplantation
- Burn Repair Surgery
- Bridges for Transplantation
- Transplant Rejections
- Organ Transport Systems
- Commercialization of Organs
- Organ Donations
- Legal and Ethical aspects:
- Socioeconomic factors
To share your views and research, please click here to register for the Conference.
To Collaborate Scientific Professionals around the World
Conference Date | July 15-16, 2019 | ||
Sponsors & Exhibitors |
|
||
Speaker Opportunity Closed | Day 1 | Day 2 | |
Poster Opportunity Closed | Click Here to View |
Useful Links
Special Issues
All accepted abstracts will be published in respective Our International Journals.
- Journal of Transplantation Technologies & Research
- Journal of Clinical and Experimental Transplantation
- Medical Safety & Global Health
Abstracts will be provided with Digital Object Identifier by